Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Première étude randomisée, multicentrique, contrôlée en double insu, étudiant l'efficacité du sulforaphane versus placebo chez des patients atteints d'un cancer de la prostate en échappement biologique après prostatectomie totale±radiothérapie externe.

Cipolla B, Mandron E, Lefort J, Coadou Y, Negra ED, Corbel L, Le Scodan R, Mottet N.

Prog Urol. 2014 Nov;24(13):820-1. doi: 10.1016/j.purol.2014.08.083. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461609
2.

Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy.

Cipolla BG, Mandron E, Lefort JM, Coadou Y, Della Negra E, Corbel L, Le Scodan R, Azzouzi AR, Mottet N.

Cancer Prev Res (Phila). 2015 Aug;8(8):712-9. doi: 10.1158/1940-6207.CAPR-14-0459. Epub 2015 May 12.

3.

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

Cao KI, Lebas N, Gerber S, Levy C, Le Scodan R, Bourgier C, Pierga JY, Gobillion A, Savignoni A, Kirova YM.

Ann Oncol. 2015 Jan;26(1):89-94. doi: 10.1093/annonc/mdu488. Epub 2014 Oct 29.

PMID:
25355723
4.

[Indication of radiotherapy after neoadjuvant chemotherapy in breast cancer].

Selz J, Le Scodan R, Ménard J, Hennequin C, Quero L.

Cancer Radiother. 2014 Jun;18(3):229-34. doi: 10.1016/j.canrad.2013.12.009. Epub 2014 May 10. Review. French.

PMID:
24819247
5.

[Prognostic factors for patients with brain metastases].

Le Scodan R, Massard C, Noël G.

Bull Cancer. 2013 Jan 1;100(1):45-50. doi: 10.1684/bdc.2012.1679. Review. French.

6.

Identification of new candidate therapeutic target genes in triple-negative breast cancer.

Glénisson M, Vacher S, Callens C, Susini A, Cizeron-Clairac G, Le Scodan R, Meseure D, Lerebours F, Spyratos F, Lidereau R, Bièche I.

Genes Cancer. 2012 Jan;3(1):63-70. doi: 10.1177/1947601912449832.

7.

Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy.

Selz J, Stevens D, Jouanneau L, Labib A, Le Scodan R.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1123-32. doi: 10.1016/j.ijrobp.2012.02.047. Epub 2012 May 8.

PMID:
22572073
8.

[Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma].

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

Cancer Radiother. 2012 Apr;16(2):128-35. doi: 10.1016/j.canrad.2011.10.013. Epub 2012 Feb 15. French.

PMID:
22341508
9.

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death.

Le Scodan R, Jouanneau L, Massard C, Gutierrez M, Kirova Y, Cherel P, Gachet J, Labib A, Mouret-Fourme E.

BMC Cancer. 2011 Sep 19;11:395. doi: 10.1186/1471-2407-11-395.

10.

Profiling of EGFR mRNA and protein expression in 471 breast cancers compared with 10 normal tissues: a candidate biomarker to predict EGFR inhibitor effectiveness.

Meseure D, Vacher S, Drak Alsibai K, Trassard M, Susini A, Le Ray C, Lerebours F, Le Scodan R, Spyratos F, Marc Guinebretiere J, Lidereau R, Bieche I.

Int J Cancer. 2012 Aug 15;131(4):1009-10. doi: 10.1002/ijc.26434. Epub 2011 Nov 30. No abstract available.

11.

[Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].

Le Scodan R, Bruant S, Selz J, Bollet MA, Daveau C, de la Lande B, Lerebours F, Labib A, Stevens D.

Cancer Radiother. 2011 Dec;15(8):675-82. doi: 10.1016/j.canrad.2011.04.004. Epub 2011 Aug 9. French.

PMID:
21831686
12.

Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.

Le Scodan R, Massard C, Jouanneau L, Coussy F, Gutierrez M, Kirova Y, Lerebours F, Labib A, Mouret-Fourme E.

J Neurooncol. 2012 Jan;106(1):169-76. doi: 10.1007/s11060-011-0654-x. Epub 2011 Jul 7.

PMID:
21735114
13.

Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e145-52. doi: 10.1016/j.ijrobp.2011.03.013. Epub 2011 May 24.

PMID:
21605948
14.

[Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].

Gutierrez M, Lyazidi S, Brasseur L, Cvitkovic F, Le Scodan R.

Bull Cancer. 2011 Apr;98(4):417-24. doi: 10.1684/bdc.2011.1341. Review. French.

15.

[Brain metastases from breast cancer: usefulness and limits of prognostic scores].

Le Scodan R, Massard C, Jouanneau L, Gutierrez M, Mouret-Fourme E.

Bull Cancer. 2011 Apr;98(4):377-84. doi: 10.1684/bdc.2011.1344. Review. French.

16.

[Concurrent whole-brain radiotherapy with trastuzumab for treatment of brain metastases in breast cancer patients: questions and answers].

Riahi Idrissi H, Chargari C, Bollet MA, Le Scodan R, Olivier L, Dorval T, Marchand V, Cottu P, Dieras V, Campana F, Fourquet A, Kirova YM.

Bull Cancer. 2011 Apr;98(4):425-32. doi: 10.1684/bdc.2011.1342. Review. French.

17.

Breast mass with intense 99mTc-diphosphonate uptake revealing primary breast osteosarcoma.

Coussy F, Le Scodan R, Guinebretiere JM, Langer A, Lerebours F.

J Clin Oncol. 2011 May 20;29(15):e428-30. doi: 10.1200/JCO.2010.33.6719. Epub 2011 Mar 7. No abstract available.

PMID:
21383295
18.

Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.

Le Scodan R, Selz J, Stevens D, Bollet MA, de la Lande B, Daveau C, Lerebours F, Labib A, Bruant S.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e1-7. doi: 10.1016/j.ijrobp.2010.12.054. Epub 2011 Mar 4.

PMID:
21377284
19.

[Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma].

Le Scodan R, Mornex F, Partensky C, Mercier C, Valette PJ, Ychou M, Bibeau F, Scoazec JY.

Cancer Radiother. 2011 Apr;15(2):97-105. doi: 10.1016/j.canrad.2010.06.019. Epub 2010 Nov 16. Review. French.

PMID:
21084206
20.

Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases.

Le Scodan R, Ali D, Stevens D.

BMC Cancer. 2010 Nov 17;10:630. doi: 10.1186/1471-2407-10-630.

21.

[Role of lymph node irradiation in breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy: the René-Huguenin Cancer Center experience].

Daveau C, Stevens D, Labib A, Berges O, Moisson P, De la Lande B, Le Scodan R.

Cancer Radiother. 2010 Dec;14(8):711-7. doi: 10.1016/j.canrad.2010.03.019. Epub 2010 Jul 31. French.

PMID:
20674445
22.

Treatment of the primary tumor in breast cancer patients with synchronous metastases.

Ali D, Le Scodan R.

Ann Oncol. 2011 Jan;22(1):9-16. doi: 10.1093/annonc/mdq301. Epub 2010 Jun 7. Review.

PMID:
20530202
23.

[National breast cancer brachytherapy survey in France: Results and perspectives in 2009].

Hannoun-Lévi JM, Hennequin C, Pommier P, Izar F, Thomas L, Le Scodan R, Lesaunier F, Nguyen T, Heymann S, Truc G, Peiffert D.

Cancer Radiother. 2010 Jun;14(3):176-82. doi: 10.1016/j.canrad.2010.01.007. Epub 2010 Apr 27. French.

PMID:
20427220
24.

Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?

Daveau C, Stevens D, Brain E, Berges O, Villette S, Moisson P, Gardner M, De la Lande B, Lasry S, Labib A, Le Scodan R.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):337-42. doi: 10.1016/j.ijrobp.2009.08.053. Epub 2010 Feb 18.

PMID:
20171795
25.

DNA repair gene expression and risk of locoregional relapse in breast cancer patients.

Le Scodan R, Cizeron-Clairac G, Fourme E, Meseure D, Vacher S, Spyratos F, de la Lande B, Cvitkovic F, Lidereau R, Bieche I.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):328-36. doi: 10.1016/j.ijrobp.2009.07.1735. Epub 2010 Jan 21.

PMID:
20092964
26.

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.

Le Scodan R, Mornex F, Girard N, Mercier C, Valette PJ, Ychou M, Bibeau F, Roy P, Scoazec JY, Partensky C.

Ann Oncol. 2009 Aug;20(8):1387-96. doi: 10.1093/annonc/mdp015. Epub 2009 Jun 5.

PMID:
19502533
27.

Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.

Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S, Gutierrez M, Ali D, Gardner M, Moisson P, Villette S, Lerebours F, Munck JN, Labib A.

J Clin Oncol. 2009 Mar 20;27(9):1375-81. doi: 10.1200/JCO.2008.19.5396. Epub 2009 Feb 9.

PMID:
19204198
28.

Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.

Le Scodan R, Mornex F, Partensky C, Mercier C, Valette PJ, Ychou M, Roy P, Scoazec JY.

Am J Clin Oncol. 2008 Dec;31(6):545-52. doi: 10.1097/COC.0b013e318172d5c5.

PMID:
19060585
29.

Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.

Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen-Solal C, De Lalande B, Moisson P, Breton-Callu C, Gardner M, Goupil A, Renody N, Floiras JL, Labib A.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):839-45. Epub 2007 Jun 4.

PMID:
17544592
30.

UV-light induced radiation recall dermatitis after a chemoradiotherapy organ preservation protocol.

Le Scodan R, Wyplosz B, Couchon S, Housset M, Laccourreye O.

Eur Arch Otorhinolaryngol. 2007 Sep;264(9):1099-102. Epub 2007 Apr 6.

PMID:
17415577
31.

[Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].

Deberne M, Huguet F, Le Scodan R, Hammel P, Andre T.

Bull Cancer. 2007 Jan;94(1):72-80. Review. French.

32.

Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients.

Le Scodan R, Pommier P, Ardiet JM, Montbarbon X, Malet C, Favrel V, Zrounba P, Poupart M, Céruse P, Ferlay C, Clippe S.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):441-8.

PMID:
16168837

Supplemental Content

Loading ...
Support Center